As of 2024-12-15, the EV/EBITDA ratio of NantHealth Inc (NH) is -8.90. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NH's latest enterprise value is 336.09 mil USD. NH's TTM EBITDA according to its financial statements is -37.78 mil USD. Dividing these 2 quantities gives us the above NH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 17.0x | 14.8x |
| Forward P/E multiples | 16.4x - 22.3x | 17.9x |
| Fair Price | (122.80) - (125.75) | (122.46) |
| Upside | -9196.5% - -9414.4% | -9171.1% |
| Date | EV/EBITDA |